Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Understanding sex and gender differences can improve personalized dermatology care.

PRP therapy helps skin heal and improve by promoting cell growth and repair.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Non-invasive imaging techniques improve scalp condition diagnosis and patient quality of life.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Understanding hair health and disorders is important for effective treatment.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Trichoscopy helps effectively tell apart different types of patchy hair loss in Egyptian patients.

Exosome treatment from stem cells improved hair regrowth and reduced scalp issues in a woman with lichen planopilaris.